The sleep disorder narcolepsy may involve more widespread brain degeneration than previously understood, potentially opening new therapeutic pathways. For decades, researchers focused on damaged hypocretin neurons in the hypothalamus as the primary culprit behind narcolepsy with cataplexy. This narrow view may have limited treatment approaches for the estimated 200,000 Americans living with this debilitating condition. Post-mortem analysis of eleven brains from individuals with narcolepsy with cataplexy revealed significant damage to a second critical brain region. The locus coeruleus, which produces norepinephrine and helps regulate arousal and attention, showed a 46% reduction in neuron count alongside an 18% increase in remaining cell size—suggesting compensatory mechanisms. Microglial clustering around both damaged hypocretin neurons and locus coeruleus cells indicates immune system involvement in the neurodegeneration process. This dual-system damage model represents a paradigm shift in narcolepsy research. The locus coeruleus contributes to wakefulness, attention, and stress response—functions clearly impaired in narcolepsy patients beyond just sleep-wake cycles. The microglial activation suggests autoimmune processes may drive both types of neuronal loss, potentially explaining why narcolepsy often emerges after infections or vaccinations. Current narcolepsy treatments primarily target symptom management rather than underlying neurodegeneration. Understanding that two interconnected brain systems deteriorate simultaneously could lead to neuroprotective strategies or immune-modulating therapies. However, this research examined only eleven brains, and the findings need replication in larger cohorts. The compensatory enlargement of surviving neurons also raises questions about whether early intervention might preserve function before irreversible damage occurs.